Evaluation of immunogenicity and protective efficacy of Actinobacillus pleuropneumoniae HB04C- mutant lacking a drug resistance marker in the pigs

Veterinary Microbiology

Volumn 125, Issue 1-2, 2007, Pages 120-127

  Bei, Weicheng ^a   He, Qigai ^a   Zhou, Rui ^a   Yan, Lin ^a   Huang, Hongliang ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Actinobacillus pleuropneumoniae; Live attenuated vaccine; RTX toxin

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE VACCINE; BACTERIAL VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BARROW (SWINE); CONTROLLED STUDY; DRUG SAFETY; GRAM NEGATIVE INFECTION; IMMUNIZATION; IMMUNOGENICITY; MALE; NONHUMAN; PROVOCATION TEST;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; COMPLEMENT FIXATION TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; INJECTIONS, INTRAMUSCULAR; LUNG; MALE; RANDOM ALLOCATION; SWINE; SWINE DISEASES;

ACTINOBACILLUS PLEUROPNEUMONIAE; MUS; MYCOPLASMA; SUIDAE;

EID: 34548843876     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2007.05.013     Document Type: Article

References (19)

1. Boekema B.K., Kamp E.M., Smits M.A., Smith H.E., and Stockhofe-Zurwieden N. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Vet. Microbiol. 100 (2004) 17-23
2. Cho W.S., and Chae C. PCR detection of Actinobacillus pleuropneumoniae apxIV gene in formalin-fixed, paraffin-embedded lung tissues and comparison with in situ hybridization. Lett. Appl. Microbiol. 37 (2003) 56-60
3. Fedorka-Cray P.J., Huether M.J., Stine D.L., and Anderson G.A. Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine. Infect. Immun. 58 (1990) 358-365
4. Hoffman L.J. Actinobacillus (Haemophilus) pleuropneumoniae: use of coagglution and complement fixation to determine the relationship between presence of organism and antibody titer in slaughterhouse pigs. J. Vet. Diagn. Invest. 1 (1989) 12-15
5. Inzana T.J., Todd J., and Veit H.P. Safety, stability, and efficacy of noncapsulated mutants of Actinobacillus pleuropneumoniae for use in live vaccines. Infect. Immun. 61 (1993) 1682-1686
6. Leiner G., Franz B., Strutzberg K., and Gerlach G.-F. A novel enzyme-linked immunosorbent assay using the recombinant Actinobacillus pleuropneumoniae ApxII antigen 3 for diagnosis of pleuropneumonia in pig herds. Clin. Diagn. Lab. Immunol. 6 (1999) 630-632
7. Mekalanos J.J. Live attenuated vaccine vectors. Int. J. Technol. Assess. Health Care 10 (1994) 131-142
8. Nielsen R. Serological and immunological studies of pleuropneumonia in swine caused by Haemophilus parahaemolyticus. Acta Vet. Scand. 15 (1974) 80-89
9. Nielsen R. Haemophilus pleuropneumoniae serotype: cross protection experiments vaccination. Nord. Vet. Med. 36 (1984) 221-234
10. Prideaux C.T., Lenghaus C., Krywult J., and Hodgson A.L.M. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Infect. Immun. 67 (1999) 1962-1966
11. Qigai H., Guiping W., Junfa L., Huanchun C., Hanhua Z., Zhengfei L., Mengyuan L., and Bin W. Isolation and identification of Actinobacillus pleuropneumonaie. Chin. J. Prev. Vet. Med. 5 (2003) 9-10 (in Chinese)
12. Rayamajhi N., Shin S.J., Kang S.G., Lee D.Y., Ahn J.M., and Yoo H.S. Development and use of a multiplex polymerase chain reaction assay based on Apx toxin genes for genotyping of Actinobacillus pleuropneumoniae isolates. J. Vet. Diagn. Invest. 17 (2005) 359-362
13. Rosendal S., and MacInnes J.I. Characterization of an attenuated strain of Actinobacillus pleuropneumoniae, serotype 1. Am. J. Vet. Res. 51 (1990) 711-717
14. Rosendal S., Carpenter D.S., Mitchell W.R., and Wilson M.R. Vaccination against pleuropneumonia of pigs caused by Haemophilus pleuropneumoniae. Can. Vet. 22 (1981) 34-35
15. Thacker B.J., and Mulks M.H. Evaluation of commercial Haemophilus pleuropneumoniae vaccines. Proc. Int. Pig Vet. Soc. 10 (1988) 87
16. Tonpitak W., Baltes N., Hennig-Pauka I., and Gerlach G.F. Construction of an Actinobacillus pleuropneumoniae serotype 2 prototype live negative-marker vaccine. Infect. Immun. 70 (2002) 7120-7125
17. Utrera V., Pijoan C., and Molitor T. Evaluation of the immunity induced in pigs after infection with a low virulence strain of A. pleuropneumoniae serotype 1. Proc. Int. Pig Vet. Soc. 12 (1992) 213
18. Wangwang L., Qigai H., Zhengfei L., Huanchun C., Bin W., Xiaojuan X., and Tao L. Clone and expression of ApxII and development an indirect ELISA for detection of antibody against A. pleuropneumoniae. Chin. J. Vet. 2 (2005) 145-147 (in Chinese)
19. Weicheng B., Qigai H., Lin Y., Liurong F., Yadi T., Shaobo X., Rui Z., Meilin J., Aizhen G., Jianqinang L., Hongliang H., and Huanchun C. Construction and characterization of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol. Lett. 243 (2005) 21-27